Portfolio news 0

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies - ONT and Genomics England announce new strategic research project to resolve undiagnosed rare disease cases

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies - Apple showcases Oxford Nanopore in M3 silicon chip launch

Tissue Regenix Group plc

Tissue Regenix - HPRA approval & distribution agreement in Spain

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies - ONT and Saphetor announce a new partnership to deliver tertiary analysis for comprehensive interpretation of nanopore sequencing

Quantum Dice

Quantum Dice - Launches The New Generation Of APEX, The World’s Fastest Quantum Random Number Generator Enabling Trusted Cybersecurity For Enterprise Applications

Featurespace Limited

Featurespace Ltd - Launches TallierLTM™ for the Financial Services and Payments Industry

Oxular

Oxular Limited - Oxular Doses First Patients in OXEYE Phase 2 Clinical Trial of Suprachoroidal OXU-001 as a Long-Acting Treatment for Diabetic Macular Edema

Artios Pharma

Artios Pharma - Presents Positive Initial Phase 1/1b Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023

Iksuda Therapeutics Ltd

Iksuda Therapeutics - Announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2

First Light Fusion Ltd

First Light Fusion - Appoints Head of Power Plant as it targets commercial fusion in 2030